1. Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor—Darolutamide

   • Eva Podgoršek
   • Niven Mehra
   • Nielka P. van Erp

   Review Article Open access 17 July 2023 Pages: 1049 - 1061

   

2. Clinical Pharmacology of Brigatinib: A Next-Generation Anaplastic Lymphoma Kinase Inhibitor

   • Neeraj Gupta
   • Michael J. Hanley
   • Vikram Sinha

   Review Article Open access 26 July 2023 Pages: 1063 - 1079

   

3. Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancy

   • Takuto Takahashi
   • Masahiro Teramoto
   • Katsuji Kaida

   Original Research Article 07 June 2023 Pages: 1081 - 1091

   

4. Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment

   • Hengli Zhao
   • Zhirui Zhao
   • Qing Wen

   Original Research Article 07 June 2023 Pages: 1093 - 1103

   

5. Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates

   • Bo-Hao Tang
   • Jin-Yuan Zhang
   • Wei Zhao

   Original Research Article 10 June 2023 Pages: 1105 - 1116

   

6. A Joint Pharmacokinetic Model for the Simultaneous Description of Plasma and Whole Blood Tacrolimus Concentrations in Kidney and Lung Transplant Recipients

   • Jeroen V. Koomen
   • Tim J. Knobbe
   • TransplantLines Investigators

   Original Research Article Open access 12 June 2023 Pages: 1117 - 1128

   

7. CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients

   • Ruben A. G. van Eerden
   • Nikki S. IJzerman
   • the Dutch Pharmacology Oncology Group

   Original Research Article Open access 13 June 2023 Pages: 1129 - 1139

   

8. The Activity of Members of the UDP-Glucuronosyltransferase Subfamilies UGT1A and UGT2B is Impaired in Patients with Liver Cirrhosis

   • Urs Duthaler
   • Fabio Bachmann
   • Stephan Krähenbühl

   Original Research Article Open access 16 June 2023 Pages: 1141 - 1155

   

9. Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs

   • J. M. Janssen
   • D. Damoiseaux
   • T. P. C. Dorlo

   Original Research Article Open access 23 June 2023 Pages: 1157 - 1167

   

10. A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women

    • Andrea Lukes
    • Elizabeth Migoya
    • Juan Camilo Arjona Ferreira

    Original Research Article Open access 26 June 2023 Pages: 1169 - 1182

    

11. Comment on: “External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps”

    • Meng Lv
    • Shengnan Zhang

    Letter to the Editor 23 June 2023 Pages: 1183 - 1185

12. Authors’ Reply to Lv et al.: “External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps”

    • Mehdi El Hassani
    • Amélie Marsot

    Letter to the Editor 23 June 2023 Pages: 1187 - 1188